Human Longevity & Insilico Med: AI for Longevity Science

Human Longevity, Inc. has launched a new entity called Human Life Foundation Models, Inc. This new company will focus on developing large-scale foundation models for human longevity science. What's interesting is their first major collaboration is with Insilico Medicine. This multi-year, multi-million dollar partnership aims to address the growing global longevity market, which analysts predict will reach nearly $8 trillion by 2030. Human Life Foundation Models will combine unique de-identified data from Human Longevity with Insilico Medicine's advanced artificial intelligence. The goal is to build a comprehensive AI foundation model. This model will predict disease risk, understand aging, and speed up the development of treatments to extend healthy human lifespan. The collaboration will use a privacy-preserving AI architecture. This means raw patient data stays with its owners and is not transferred or shared directly. Insilico Medicine will not have direct access to identifiable personal health data. The bottom line: This collaboration seeks to decode the biology of aging and shift medicine towards prevention, potentially impacting global health.